This strategy was applied by Purcell et al. who identified Leucine-rich-repeat-containing 15 (LRRC15) as a new surface marker for CAFs in multiple solid tumors including breast, head and neck, lung, pancreatic cancer. Here, LRRC15 is linked to pancreatic neoplasm.